Researchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses of vaccine in pre-clinical testing.
The lead researcher, Dr Anne Moore, heads to Silicon Valley next week to meet venture capitalists and leading technology companies with a view to commercialising the research.
The microneedle-based patch also overcomes one of the main problems with this type of vaccine which relates to overcoming pre-existing immunity to the vaccine. The scientists combined two vaccine technologies to determine if immunity could be further enhanced and the research suggests that using a microneedle patch would overcome the need to make and use multiple different vaccine types to induce protective immunity to some of the world’s biggest killers. This could have significant consequences on the costs and logistics of vaccination.
The work was carried out by researchers in the School of Pharmacy, Dept. of Pharmacology and the Tyndall National Institute, UCC, led by Dr Anne Moore in collaboration with colleagues at the Jenner Institute, University of Oxford and was published byNature Publication Group in Scientific Reports and funded by Enterprise Ireland and Science Foundation Ireland. Dr Moore’s visit to Silicon Valley is being hosted by the Irish Technology Leadership Group (ITLG) as part of an SFI initiative for researchers to help them develop their entrepreneurial skills in the Get Started Venture Technology programme.
The skin patch has arrays of tiny silicon ‘microneedles’ that painlessly create temporary pores in the very outermost barrier layer of the skin, permitting the vaccine to flow into the skin, which is rich in cells of the immune system. The experimental vaccine was based on a live adenovirus. This virus is similar to those that can cause a common cold, but is engineered to be safer and to deliver a protein from the malaria-causing parasite, to the immune system.
The Latest on: Malaria vaccine
[google_news title=”” keyword=”Malaria vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Malaria vaccine
- Kenya is gripped by deadly malaria. Could a new locally produced drug be gamechanger?on May 12, 2024 at 4:21 am
The WHO approved a Kenya-based pharma company to produce a crucial antimalarial drug locally, reducing reliance on imports from India and China. View on euronews ...
- An adjuvant made in yeast could lower vaccine cost and boost availabilityon May 8, 2024 at 9:57 am
Adjuvants make vaccines more effective, though one of the best is an expensive extract from the soap bark tree. To lower the cost and avoid the laborious extraction process from bark, synthetic ...
- R21 anti-malaria vaccine is a game changer. The scientist who designed it reflects on 30 years of research, and its hopeful promises.on May 8, 2024 at 7:30 am
Until three years ago nobody had developed a vaccine against any parasitic disease. Now there are two against malaria: the RTS,S and the R21 vaccines.
- An Engineered Antibody Can Prevent Malariaon May 8, 2024 at 5:34 am
Mosquitoes are one of the deadliest animals on earth because they transmit diseases including malaria, which is thought to be responsible for the deaths of... | Microbiology ...
- Ghana: Enhancing capacity for malaria vaccine introduction and rollout in Africa through experience sharingon May 7, 2024 at 5:00 pm
Since 2019, Ghana, Kenya and Malawi have been rolling out malaria vaccines, with over 2.5 million children already receiving at least one dose of the life-saving vaccine that is protecting children ...
- Deeper understanding of malaria parasite sexual development unlocks opportunities to block disease spreadon May 2, 2024 at 11:00 am
For the first time, the developmental stages of the deadliest human malaria parasite have been mapped in high resolution, allowing researchers to understand this ever-adapting adversary in more detail ...
- R21 anti-malaria vaccine is a game changer: scientist who helped design it reflects on 30 years of research, and what it promiseson April 28, 2024 at 1:00 am
More than 600,000 people die of malaria each year. With low-cost, very effective vaccines being deployed we should be able to get this down to 200,000 or less by the end of this decade then the ...
- West Africa's Benin, Liberia and Sierra Leone launch malaria vaccinationon April 25, 2024 at 10:59 am
COTONOU, April 25 (Reuters) - Benin, Liberia and Sierra Leone launched large-scale malaria vaccine programmes on Thursday under an Africa-focused initiative that hopes to save tens of thousands of ...
- Three more African nations roll out malaria vaccineon April 25, 2024 at 10:40 am
Three more African countries have joined a rollout of malaria vaccines targeting millions of children in a continent that accounts for 95 percent of malaria deaths, the UN said Thursday.
- Vaccines are a glimmer of hope against malaria, but the battle has only just begunon April 25, 2024 at 6:10 am
By the time you reach the end of this article, three children will have died from malaria – a disease that casts a dark shadow over nearly half of the world’s population, claiming victims ...
via Bing News